YOPI Technologies

Sweat Analysis System for Real-time Health Monitoring

Health Tech & Life Sciences
Active
Seed Nir Am Founded 2017
Total raised
$2.1M
Last: Equity crowdfunding 2023-05
Stage
Seed
Founded
2017
Headcount
11
HQ
Nir Am
Sector
Health Tech & Life Sciences

About

Yopi Technologies is at the forefront of wearable health innovation, offering a groundbreaking solution for real-time cardiovascular health monitoring. By combining advanced biomarker analysis, AI-driven insights, and cloud integration, Yopi transforms how individuals and healthcare providers monitor and manage heart health. With a strong foundation of patented technology, an experienced leadership team, and a clear path to market, Yopi is well-positioned to capture a significant share of the growing wearable medical device market. The Need Cardiovascular diseases (CVDs) are a leading cause of mortality globally, often manifesting without early symptoms. Early detection and proactive monitoring are critical to prevent life-threatening conditions such as heart attacks. However, existing methods for cardiovascular health monitoring are either invasive, cumbersome, or limited to clinical environments, leaving a gap for practical, real-time solutions. The Solution Yopi Technologies addresses this gap by offering an innovative wearable device that analyzes sweat biomarkers in real-time to provide actionable insights into cardiovascular health. Designed for use during physical activity, Yopi's device leverages artificial intelligence (AI) and machine learning (ML) to deliver key physiological metrics, such as oxygen consumption (VO₂), directly to users' smartphones. This data, stored securely in Yopi's cloud, enables continuous health monitoring and early detection of conditions like coronary artery disease. In essence, Yopi provides a comprehensive metabolic lab on your wrist, empowering users to proactively manage their health. Technology

Funding history · 3 rounds · $2.1M total

2023-05
Equity crowdfunding $500K
2022-06
Undisclosed Undisclosed
2019-12
Seed $550K

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is YOPI Technologies' core product?
YOPI Technologies offers an innovative wearable device that analyzes sweat biomarkers in real-time to provide insights into cardiovascular health, delivering physiological metrics like oxygen consumption (VO₂) to users' smartphones.
When was YOPI Technologies founded?
YOPI Technologies was founded in November 2017.
What was YOPI Technologies' most recent funding round?
YOPI Technologies completed an Equity Crowdfunding round in May 2023, raising $500,000. For full financing history, please refer to startupim.
Which investor participated in YOPI Technologies' Seed round?
F&F participated in YOPI Technologies' Seed round in December 2019.
Did YOPI Technologies receive any grants?
Yes, YOPI Technologies received a grant of $1,070,000 from the IIA in May 2021.
What is the current employee count for YOPI Technologies?
YOPI Technologies currently has 11 employees.
What is the primary sector of YOPI Technologies?
YOPI Technologies' primary sector is Health Tech & Life Sciences.
Has YOPI Technologies been featured in news regarding its technology?
Yes, in July 2023, The Jerusalem Post reported on YOPI Technologies' wearable AI device that reads sweat for heart health information.
What is YOPI Technologies' total funding raised to date?
According to startupim data, YOPI Technologies has raised a total of $2,120,000 USD.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Monitors
Technologies
Platforms & InterfacesMobileArtificial IntelligenceMachine LearningSensing
Target customers
ConsumersRecreational & LifestyleFitness & Sports
Business model
B2CB2B2C

Highlights

1 PatentsVerified

Tags

sensorsmhealthmobile-applicationsartificial-intelligencepatent-pendingdata-analyticswearablemachine-learningbiosensorsmonitoringhealth-managementsports-techfitnessdigital-healthcareathletesdigital-therapeuticsconsumersreal-timewearable